REGISTER FOR TOUCH BRIEFINGS |
|
|
|
Register for touch briefings
|
|
|
|
|
|
|
|
Touch Briefings welcomes editorial submissions for inclusion within our print reports and website from industry practitioners.
|
|
|
|
|
|
EUROPEAN RENAL DISEASE 2007 - ISSUE I - JULY 2007 |
|
Contents:
Contents
Advisory Panel
Foreword
|
Foreword
Jorge B Cannata-Andía
President, European Renal Association – European Dialysis and Transplant Association (ERA-EDTA)
|
Current Issues
|
Acute Kidney Injury Definition – RIFLE Is Shooting Well
Claudio Ronco1 and Zaccaria Ricci2
1. Director, Department of Nephrology, Dialysis and Transplantation, St Bortolo Hospital, Vicenza;
2. Staff Anaesthesiologist, Department of Paediatric Cardiac Surgery, Bambino Gesù Hospital, Rome
|
|
Chronic Kidney Disease – Into the 21st Century
Meguid El Nahas,1,2 Bisher Kawar1 and Mohsen El Kossi1
1. Sheffield Kidney Institute 2. Northern General Hospital, Sheffield
|
Anaemia Management
|
Erythropoiesis-stimulating Agents in Chronic Kidney Disease – for Better or for Worse
Nathalie Thilly1 and Luc Frimat2
1. Associate Professor and Lecturer, Epidemiology and Public Health;
2. Professor of Nephrology, University Hospital of Nancy
|
Phosphorus Control
|
Slowing the Progression of Vascular Calcification in Chronic Kidney Disease Patients
Jordi Bover, Cristina Canal, Susana G Pérez, Ricardo J Bosch and José A Ballarín
Fundació Puigvert, Hospital de la Santa Creu i Sant Pau, Barcelona; Universitat Autònoma de Barcelona/FP and Physiology Department, Universidad de Alcalá de Henares, Madrid
|
|
Phosphorus Control in Chronic Kidney Disease
Markus Ketteler
Division Chief of Nephrology, Klinikum Coburg, University of Würzburg
|
|
Control of Phosphate
Dominique Prié
Department of Clinical Investigation, Hôpital Necker Paris and Member, INSERM U845
|
|
Phosphate Control in Renal Disease
Fouad Albaaj1 and Alastair J Hutchison2
1. Consultant Nephrologist, Queen Elizabeth and City Hospitals, Birmingham 2. Consultant Nephrologist and Clinical Director, Renal Unit, Manchester Royal Infirmary
|
Renal Bone Disease
|
Renal Osteodystrophy
Martin Haas
Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University Vienna
|
Cardiovascular Risk
|
Accuracy of a Home Blood Pressure Monitor Tested in End-stage Renal Disease Patients
Aliza M Thompson, Kazuo Eguchi, Michael E Reznik, Samir S Shah and Thomas G Pickering
Department of Medicine, Behavioural Cardiovascular Health and Hypertension Program, and Division of Nephrology, Columbia University
|
|
Direct Renin Inhibitors – Nuance or Necessity?
Liviu Segall,1 Kerem Atalar2 and David Goldsmith3
1. ’C I Parhon’ University Hospital, Romania 2. St Thomas’ Hospital, London 3. Guy’s Hospital, London
|
Dialysis
|
Fast Transport Status in Peritoneal Dialysis Patients – Greater Knowledge, Better Treatment
Anabela Rodrigues
Nephrology Consultant and Associate Professor of Nephrology, University of Porto
|
|
Renal Replacement Therapy in Acute Renal Failure – What Is Recommended in 2007?
Eric Rondeau
Head, Department of Intensive Care Nephrology and Transplantation, Hôpital Tenon, Paris
|
Transplantation
|
Organ Quality Determines Outcome after Kidney Transplantation
Stefan G Tullius,1 Mohamed H Sayegh1,2 and Giuseppe Remuzzi3
1. Brigham and Women’s Hospital, Harvard Medical School 2. Children’s Hospital, Harvard Medical School;
3. Ospedali Riuniti and Mario Negri Institute for Pharmacological Research, Bergamo, Italy
|
|
Kidney Transplantation
Helena Genberg, Lars Wennberg and Gunnar Tydén Karolinska University Hospital and Karolinska Institute
|
|
The Influence of Various Immunosuppressive Regimens on Tolerance Induction in Transplant Recipients
Julien Zuber,1 Albane Brodin-Sartorius,1 Eric Thervet1 and Christophe Legendre1,2
1. Necker Hospital 2. René Descartes University, Paris
|
Nutrition
|
Present Status and Perspectives in the Treatment of Malnutrition in Haemodialysis
Noël JM Cano
Professor of Nutrition, Clermont-Ferrand University School of Medicine, Montpied Hospital, France
|
|
The Role of Growth Hormone in the Treatment of Malnutrition in Adult Patients on Chronic Haemodialysis
Anne-Marie Kappelgaard,1 Martin Lange2 and Meguid El Nahas3
1. Novo Nordisk A/S, Copenhagen 2. Novo Nordisk Inc., Princeton, New Jersey;
3. Sheffield Kidney Institute, Northern General Hospital, Sheffield
|
Technology & Services
|
|
|
|
|